Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor β spectrotyping and immunohistological detection with T-cell receptor β chain variable region segment-specific antibodies

Journal of Molecular Diagnostics

Volumn 7, Issue 4, 2005, Pages 455-464

  Geissinger, Eva ^a   Bonzheim, Irina ^a   Krenács, László ^b   Roth, Sabine ^a   Ströbel, Philipp ^a   Ott, German ^a   Reimer, Peter ^c   Wilhelm, Martin ^d   Müller Hermelink, Hans Konrad ^a   Rüdiger, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAY ZOLTÁN NONPROFIT LTD FOR APPLIED RESEARCH   (Hungary)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d KLINIKUM NÜRNBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLONAL VARIATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPITOPE MAPPING; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPHOMA CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; RELIABILITY; T LYMPHOCYTE SUBPOPULATION;

EID: 26944480087     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60576-4     Document Type: Article

References (68)

1. Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Müller-Hermelink HK: Peripheral T-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Ann Oncol 2002, 13:140-149
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
3. Smith JL, Haegert DG, Hodges E, Stacey GN, Howell WM, Wright DH, Jones DB: Phenotypic and genotypic heterogeneity of peripheral T-cell lymphoma. Br J Cancer 1988, 58:723-729
4. Kagami Y, Suzuki R, Taji H, Yatabe Y, Takeuchi T, Maeda S, Kondo E, Kojima M, Motoori T, Mizoguchi Y, Okamoto M, Ohnishi K, Yamabe H, Seto M, Ogura M, Koshikawa T, Takahashi T, Kurita S, Morishima Y, Suchi T, Nakamura S: Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol 1999, 23:1184-1200
5. Lee SS, Rudiger T, Odenwald T, Roth S, Starostik P, Muller-Hermelink HK: Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 2003, 103:12-20
6. Geissinger E, Odenwald T, Lee SS, Bonzheim I, Roth S, Reimer P, Wilhelm M, Muller-Hermelink HK, Rudiger T: Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch 2004, 445:334-343
7. Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
8. Haioun C, Gaulard P, Bourquelot P, Roudot-Thoraval F, Divine M, Lavaud A, Bagot M, Vasile N, Farcet JP, Reyes F: Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study. Leuk Lymphoma 1992, 7:449-455
9. Posnett DN, Romagne F, Necker A, Kotzin B, Sekaly R-P: First human TcR monoclonal antibody workshop. Immunologist 1996, 4:5-8
10. Rowen L, Koop BF, Hood L: The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996, 272:1755-1762
11. Kazatchkine MD: Nomenclature for T-cell receptor (TCR) gene segments of the immune system: WHO-IUIS Nomenclature Sub-Committee on TCR Designation. Immunogenetics 1995, 42:451-453
12. Hall MA, Lanchbury JS: Healthy human T-cell receptor beta-chain repertoire: quantitative analysis and evidence for J beta-related effects on CDR3 structure and diversity. Hum Immunol 1995, 43:207-218
13. Rosenberg WM, Moss PA, Bell JI: Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction. Eur J Immunol 1992, 22:541-549
14. Assaf C, Hummel M, Dippel E, Goerdt S, Muller HH, Anagnostopoulos I, Orfanos CE, Stein H: High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000, 96:640-646
15. Luo V, Lessin SR, Wilson RB, Rennert H, Tozer C, Benoit B, Leonard DG: Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis. Mol Diagn 2001, 6:169-179
16. Tobinai K, Minato K, Ohtsu T, Mukai K, Kagami Y, Miwa M, Watanabe S, Shimoyama M: Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma. Blood 1988, 72:1000-1006
17. Nakamura S, Takagi N, Kitoh K, Koshikawa T, Hayashi K, Yamamoto K, Suzuki H, Oyama A, Ueda R, Suchi T: Peripheral T-cell lymphoma of AILD (angioimmunoblastic lymphadenopathy with dysproteinemia) type involving gastrointestinal tract: a morphologic, phenotypic and genotypic study. Acta Pathol Jpn 1992, 42:141-149
18. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J, Kim DS: Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 1998, 22:643-655
19. Richel DJ, Lepoutre JM, Kapsenberg JG, Ooms EC, Boom WR, Boucher CA, Kluin PM: Epstein-Barr virus in a CD8-positive T-cell lymphoma. Am J Pathol 1990, 136:1093-1099
20. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA: Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986, 67:474-478
21. Ohshima K, Kikuchi M, Hashimoto M, Kozuru M, Uike N, Kobari S, Masuda Y, Sumiyoshi Y, Yoneda S, Takeshita M, Kimura N: Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients. Virchows Arch 1994, 425:25-32
22. Nakamura N, Morimura Y, Abe M, Wakasa H: A novel monoclonal antibody specific for human pre-B cell leukemia/lymphoma. Eur J Haematol 1991, 47:168-173
23. Kaneko Y, Maseki N, Sakurai M, Takayama S, Nanba K, Kikuchi M, Frizzera G: Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" features. Blood 1988, 72:413-421
24. Knecht H, Odermatt BF, Maurer R, Ruttner JR: Diagnostic and prognostic value of monoclonal antibodies in immunophenotyping of angioimmunoblastic lymphadenopathy/lymphogranulomatosis X. Br J Haematol 1987, 67:19-24
25. Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, Kuse R, Mak TW, Lennart K: Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 1988, 133:549-556
26. Chott A, Augustin I, Wrba F, Hanak H, Ohlinger W, Radaszkiewicz T: Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases. Hum Pathol 1990, 21:1117-1125
27. Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P: Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J Pathol 1997, 183:432-439
28. Hodges E, Quin CT, Wright DH, Smith JL: Oligoclonal populations of T and B cells in a case of angioimmunoblastic T-cell lymphoma predominantly infiltrated by T cells of the VB5.1 family. Mol Pathol 1997, 50:15-17
29. Doi S, Nasu K, Arita Y, Tanabe S, Matsuyama F, Kamesaki H, Fukuhara S, Nishikori M, Miwa H, Kita K, Hatanaka M, Uchino H: Immunohistochemical analysis of peripheral T-cell lymphoma in Japanese patients. Am J Clin Pathol 1989, 91:152-158
30. Boni R, Dummer R, Dommann-Scherrer C, Dommann S, Zimmermann DR, Joller-Jemelka H, Burg G: Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia. Br J Dermatol 1995, 133:978-982
31. Kanzaki Y, Eura M, Chikamatsu K, Yoshida M, Masuyama K, Nishimura H, Ishikawa T: Angioimmunoblastic lymphadenopathy-like T-cell lymphoma: a case report and immunologic study. Auris Nasus Larynx 1997, 24:199-206
32. Lakkala-Paranko T, Franssila K, Lappalainen K, Leskinen R, Knuutila S, de la Chapelle A, Bloomfield CD: Chromosome abnormalities in peripheral T-cell lymphoma. Br J Haematol 1987, 66:451-460
33. Picker LJ, Weiss LM, Medeiros U, Wood GS, Warnke RA: Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987, 128:181-201
34. Shih LY, Kuo TT, Dunn P, Liaw SJ: HTLV-I-positive and HTLV-I-negative peripheral T-cell lymphomas in Taiwan Chinese. Int J Cancer 1992, 50:186-191
35. Montalban C, Obeso G, Gallego A, Castrillo JM, Bellas C, Rivas C: Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. Histopathology 1993, 22:303-310
36. Nakamura S, Koshikawa T, Koike K, Kitoh K, Suzuki H, Oyama A, Motoori T, Kojima M, Ogura M, Kurita S, Ueda R, Tajima K, Takahashi T, Suchi T: Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol Jpn 1993, 43:396-412
37. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH: Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997, 89:4501-4513
38. Ng CS, Lo ST, Chan JK: Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand. Hum Pathol 1999, 30:48-53
39. Feller AC, Griesser GH, Mak TW, Lennert K: Lymphoepithelioid lymphoma (Lennert's lymphoma) is a monoclonal proliferation of helper/inducer T cells. Blood 1986, 68:663-667
40. Nakamura S, Suchi T: A clinicopathologic study of node-based, low-grade, peripheral T-cell lymphoma: angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1991, 67:2566-2578
41. Takagi N, Nakamura S, Ueda R, Osada H, Obata Y, Kitoh K, Suchi T, Takahashi T: A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1992, 69:2571-2582
42. Yamashita Y, Yatabe Y, Tsuzuki T, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T, Mori N: Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 1998, 11:313-323
43. Su IJ, Wang CH, Cheng AL, Chen YC, Hsieh HC, Chen CJ, Tien HF, Tsay W, Huang SS, Hu CY, Chen PJ, Chen JY, Hsu HC, Chuang SM, Shen MC, Kadin ME: Characterization of the spectrum of postthymic T-cell malignancies in Taiwan: a clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases. Cancer 1988, 61:2060-2070
44. Krajewski AS, Myskow MW, Cachia PG, Salter DM, Sheehan T, Dewar AE: T-cell lymphoma: morphology, immunophenotype and clinical features. Histopathology 1988, 13:19-41
45. Macon WR, Salhany KE: T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry. Am J Clin Pathol 1998, 109:610-617
46. Deng X, Sun GR, Zheng Q, Li Y: Characterization of human TCR Vbeta gene promoter: role of the dodecamer motif in promoter activity. J Biol Chem 1998, 273:23709-23715
47. Lennon GP, Sillibourne JE, Furrie E, Doherty MJ, Kay RA: Antigen triggering selectively increases TCRBV gene transcription. J Immunol 2000, 165:2020-2027
48. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 1996, 273:104-106
49. Kurokawa M, Furukawa H, Yabe T, Matsui T, Toda M, Hamada C, Kasukawa R, Yamamoto K, Nishioka K, Kato T: Frequency of clonally expanded T cells evaluated by PCR from a single cell. J Immunol Methods 1999, 224:203-208
50. Lefranc M-P, Lefranc G: The T Cell Receptor Facts Book. London, Academic Press, 2001
51. Nuovo GJ, Morrison C, Porcu P, Caligiuri MA, Suster S: In situ determination of T-cell receptor beta expression patterns. J Histochem Cytochem 2001, 49:139-145
52. Hodges E, Edwards SE, Howell WM, Smith JL: Polymerase chain reaction amplification analyses of clonality in T-cell malignancy including peripheral T-cell lymphoma. Leukemia 1994, 8:295-298
53. Smith JL, Lane AC, Hodges E, Reynolds WM, Howell WM, Jones DB, Janson CH: T-cell receptor variable (V) gene usage by lymphoid populations in T-cell lymphoma. J Pathol 1992, 166:109-112
54. Smith JL, Hodges E, Quin CT, McCarthy KP, Wright DH: Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000, 156:661-669
55. Willenbrock K, Roers A, Seidl C, Wacker HH, Kuppers R, Hansmann ML: Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-beta gene rearrangements. Am J Pathol 2001, 158:1851-1857
56. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, Boor PP, van Lochem EG, Hooijkaas H, van Dongen JJ: Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood 2001, 98:165-173
57. Tissier F, Martinon F, Camilleri-Broet S, Bigorgne C, Devez F, Le Tourneau A, Diebold J, Audouin J, Molina TJ: T-cell receptor Vbeta repertoire in nodal non-anaplastic peripheral T-cell lymphomas. Pathol Res Pract 2002, 198:389-395
58. Beck RC, Stahl S, O'Keefe CL, Maciejewski JP, Theil KS, Hsi ED: Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies. Am J Clin Pathol 2003, 120:785-794
59. Robinson MA: Usage of human T-cell receptor V beta, J beta, C beta, and V alpha gene segments is not proportional to gene number. Hum Immunol 1992, 35:60-67
60. Melenhorst JJ, Eniafe R, Follmann D, Molldrem J, Kirby M, El Ouriaghli F, Barrett AJ: T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J 2003, 4:18-25
61. van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero L, Hooijkaas H, van Dongen JJ: Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000, 40:336-345
62. McCoy JP Jr, Overton WR, Schroeder K, Blumstein L, Donaldson MH: Immunophenotypic analysis of the T cell receptor V beta repertoire in CD4+ and CD8+ lymphocytes from normal peripheral blood. Cytometry 1996, 26:148-153
63. Muraro PA, Jacobsen M, Necker A, Nagle JW, Gaber R, Sommer N, Oertel WH, Martin R, Hemmer B: Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vbeta analysis. J Immunol Methods 2000, 246:131-143
64. Langerak AW, Wolvers-Tettero IL, van Dongen JJ: Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia 1999, 13:965-974
65. Rudolph MG, Wilson IA: The specificity of TCR/pMHC interaction. Curr Opin Immunol 2002, 14:52-65
66. Davis MM, Bjorkman PJ: T-cell antigen receptor genes and T-cell recognition. Nature 1988, 334:395-402
67. Casanova JL, Maryanski JL: Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol Today 1993, 14:391-394
68. Arden B, Clark SP, Kabelitz D, Mak TW: Human T-cell receptor variable gene segment families. Immunogenetics 1995, 42:455-500